(I-BusinessNews.Com, November 22, 2019 ) The report “Biological Seed Treatment Market by Type (Microbials and Botanicals), Crop (Corn, Wheat, Soybean, Cotton, Sunflower, and Vegetable Crops), Function (Seed Protection and Seed Enhancement), and Region – Global Forecast to 2022″, The biological seed treatment market was estimated at USD 739.3 Million in 2017, and is projected to reach USD 1,251.4 Million by 2022, at a CAGR of 11.10%. The market is influenced by the adoption of sustainable agricultural practices, along with strong investments being made by major market players in the research and development of these products.
Request for Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=162422288
Serves as insurance to seed investments
The commercial seed industry has been gaining better acceptance among crop growers, as the demand has been shifted toward commercialized seeds from open-hybrid and farm-saved seed varieties in many countries across the globe. Biological seed treatments have gained significant accomplishments in product developments with respect to biological coating and achieving crop efficiency at early seedling stage. Further minor innovations and improvements in product shelf-life can help in its evolution into becoming a more reliable product.
Today, these biological seed treatment products not only help in protecting the seeds, but also help in acting as seed enhancers, whereby, improving crop yields. The basic function of the initial biological seed treatment was majorly to control certain soil pathogens that affects seed performance. However, this has evolved greatly over the years and become much more complex in nature. Changes in different formulations and active ingredients have now aided these seed treatments to have a broad spectrum of protection from insects, diseases, and nematodes, with different combinations of insecticides, fungicides, and inoculants. Even though there have been field trials by key manufacturers such as BASF utilizing seed-applied agricultural inoculants to analyze the crop yields, the results are not much higher as expected due to the need to study further about the enhancing the interaction between the seed and the inoculant during sowing stage.
This has highly assisted in the reduction of biotic and abiotic stresses on the crop. Protection of the crop from abiotic stress could result in an improved seed vitality, increased stress tolerance, and aid in higher nutrient uptake. This will in turn enhance plant emergence, foliar growth, and nutrient utilization efficiency, while providing the crop with essential protection. These factors highly propel the assurance of a good crop yield, and act as an insurance to the investments made by the farmers on different seeds. Therefore, this remains as one of the most potent drivers for the commercialized seed industry in the coming decades.
The adoption of biological seed treatment products in emerging markets of India, China, Brazil, and Argentina has been expected to witness significant market growth based on the product launches of important players such as Bayer, BASF, and DuPont Pioneer. Over the last decade, there has been an increased demand for food and feed in emerging countries. As a result, there has been an increase in the demand to improve crop yield and utilize highly effective seed treatments in countries such as Brazil, which being an early adopter of these products, has led to some manufacturers to launch new biological seed treatment products in the region. For instance, Syngenta’s launch of EPIVIO brand of seed-applied biostimulant products in Brazil in 2016 for soybean, which was followed by their market outreach to corn growers in China.
High costs associated with biological seed treatments
While investing in commercialized seeds, farmers spend more than what is invested in for traditional seeds. These costs further increase when expenses are made specifically for genetically modified seeds (GM) seeds or hybrid seeds. Although such GM seeds assure farmers with better yields, the higher supply of GM crops, especially corn and soybeans, and increased demand for non-GMO foods, have led to a decline in the prices of these crops. Additionally, despite such seeds assuring better yields, farmers are still required to spend on crop protection products such as pesticides and herbicides, which further increase farmer costs. These production expenses make it very difficult for farmers to further invest in seed treatment products, which act as an insurance to better yields.
Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=162422288
North America is projected to be the fastest-growing market
The major reason for the biological seed treatment market experiencing such a high growth rate is the highly streamlined product registration process, which makes it easier for most private companies to launch their products easily. Lower investment requirement and limited gestation period involved in the development and commercialization of biological products are key factors attracting a large number of startup companies in the industry. Additionally, growing awareness among consumers against synthetic chemicals has also led to a higher adoption of these products.
This report includes a study of marketing and development strategies, along with the product portfolios of leading companies. It also includes the profiles of leading companies such as BASF (Germany), Bayer (Germany), Syngenta (Switzerland), Monsanto (US), DuPont (US), Valent BioSciences (US), Verdesian Life Sciences (US), Plant Health Care (US), Precision Laboratories (US), Koppert (Netherlands), Italpollina (Italy), and Incotec (Netherlands).
MarketsandMarkets™
Mr. Shelly Singh
1-888-600-6441
raviraj.tak@marketsandmarkets.com
Source: EmailWire.Com 
